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Abstract: This study was conducted to investigate the histopathological and biochemical effects of midazolam and etomidate, which
are intravenous anesthetics used in surgical operations, on rat liver. There were 3 study groups each consisting of 9 animals: the control,
midazolam, and etomidate groups. Midazolam and etomidate were administered 10 times with 1-day intervals. At the end of the study,
tissues were taken for histological examination and biochemical analysis. We determined superoxide dismutase (SOD), catalase (CAT),
and malondialdehyde (MDA) levels in the liver. There was a slight increase in MDA level in the midazolam-exposed group when
compared with the controls, and this was not statistically significant. However, SOD and CAT activities were significantly increased in
the midazolam group. We found slight damage in histological sections in parallel to biological findings. MDA levels were significantly
increased in the etomidate group and SOD and CAT activities were also prominent in this group. More histological changes like
hepatocyte degeneration, vascular congestion, and mononuclear cell infiltration were observed in the etomidate group and this was
statistically significant. We can say that these intravenous anesthetic agents may cause dose-dependent damage in tissue. Therefore, we
think that one must be cautious of the administration duration and dose levels of anesthetics during surgical operations.
Key words: Catalase, etomidate, liver, malondialdehyde, midazolam, superoxide dismutase

1. Introduction
Inhalation anesthetics exert their effects in a short time
period. Some risk factors like air contamination in the
surgery room and toxicity are present while using these
agents. For this reason, intravenous anesthetics are widely
preferred in current practice (Reves et al., 1987). An ideal
anesthetic agent should fulfill some criteria such as rapid
effect during surgical operations, absence of toxicity in
tissues and organs, large confidence interval, and short
awakening time right after the cessation of anesthesia
application (Aitkenhead and Smith, 1990; Rang, 1995;
Trevor and Miller, 1998). Although huge improvement
has been established in intravenous agent research, there
are still some issues with toxicity. Toxic effect can be
caused by the agent or its solution in water (Sear, 1987).
Midazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4Himidazo(1,5-a)(1,4) benzodiazepine) is a benzodiazepinederived intravenous anesthetic agent with short half-life in
the body (Khanderia and Pandit, 1987).
Midazolam is a widely used short-acting
benzodiazepine with hypnotic, sedative, anticonvulsant,
* Correspondence: dilekbayram@sdu.edu.tr

muscle-relaxant, amnesic, and anxiolytic properties (Jabor
et al., 2005; Emoto and Iwasaki, 2007). Midazolam is
preferred over diazepam because of its shorter induction
and recovery times and its marked amnesic properties
(Lichtenstein et al., 2008; Riphaus et al., 2009; Correia et al.,
2011). About half (40%–50%) the amount of midazolam
is rapidly metabolized in the liver via hydroxylation
and subsequent glucuronidation reactions (Vinik et al.,
1981). At lower doses, midazolam has muscle relaxation,
anxiolytic, amnestic, and sedative effects, whereas at
higher doses it can lead to stupor and unconsciousness
(Jong and Bonin, 1981; Riphaus et al., 2009). Etomidate
is a carboxylated imidazole-derived general anesthetic
agent (Reves et al., 1987). Etomidate is used especially in
cases such as heart or lung transplantation, reactive airway
disease, and intracranial pressure increment (Krumholz
et al., 2001). Etomidate is eliminated primarily in liver
via ester hydrolysis or N-dealkylation mechanisms (Reves
et al., 1999). Etomidate shows its depressant effects on
reticular formation, similar to those of the barbiturate
derivatives, and it also has inhibitor effects on spinal
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neurons (Işık, 2004). However, etomidate at 0.4 µg/mL
has no significant effect on isolated rat liver mitochondria,
but at 4 µg/mL it can lead to disruption of mitochondrial
energy metabolism of rat livers in vitro (Liu et al., 2009). In
previous studies, it has been reported that some anesthetic
agents administered via inhalation or intravenous
routes could lead to decrease in hepatic blood flow or
hepatotoxicity (Hanquet, 1972; Fassoulaki et al., 1986;
Atiba et al., 1988).
Free radicals affect important cellular components
such as lipids, proteins, DNA, and carbohydrates. They
have affinity to macromolecules such as phospholipids,
glycolipids, unsaturated lipid acids of glycerides, and
membrane proteins (Codogan, 1973). There are many
studies reporting that some intravenous anesthetic agents
may lead to an increase in reactive oxygen species and
consequent tissue damage (Fassoulaki et al., 1986; Murphy
et al., 1993; Okutomi et al., 1995; Abidova, 2002). In this
study, we aimed to investigate the effects of midazolam and
etomidate on liver tissue, lipid peroxidation, antioxidant
defense system, and histopathological changes.
2. Materials and methods
2.1. Experimental conditions
Twenty-seven male Wistar albino rats weighing between
180 and 240 g were obtained from the Süleyman Demirel
University Laboratory of Animal Science (Isparta, Turkey).
The rats were housed in Makrolon cages under standard
laboratory conditions (light period 0700 to 1900 hours; 21
± 1 °C). Animals were maintained and used in accordance
with the Animal Welfare Act and the Guide for the Care
and Use of Laboratory Animals as prepared by Süleyman
Demirel University.
The rats were divided into three groups as follows:
control group (n = 9), midazolam group (n = 9), and
etomidate group (n = 9). Midazolam (F. HoffmannLa Roche Ltd., Switzerland) was intraperitoneally
administered at a dose of 3 mg/kg for 20 days with 1-day
intervals. Etomidate (B. Braun Melsungen AG, Germany)
was intraperitoneally injected at a dose of 20 mg/kg for
20 days with 1-day intervals (Lee et al., 2000; MolinaHernandez and Tellez-Alcantara, 2001). Two of the
animals died during this period.
At the end of the experimental period, all rats
were sacrificed and liver tissues were collected for
histopathological and biochemical analysis.
2.2. Histopathological examination
Liver tissue samples were fixed with 10% neutral formalin
and then routine light microscopic techniques were used
on the tissue samples. Paraffin-embedded blocks were
cut at 3–5 µm and stained with hematoxylin and eosin
(H&E). The slides were then examined using a light
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microscope (Olympus BX 50, Japan) and photographed.
All histological evaluations were made twice under blind
conditions (without knowledge of the treatment). The
histopathological findings were graded according to the
degree of changes (Abdel-Wahhab et al., 1999).
2.3. Biochemical examination
The frozen tissue samples of liver were weighed and
homogenized (Ultra Turrax T25, Germany) (1:10, w/v) in
50 mM L–1 phosphate buffer (pH 7.4) kept on an ice bath.
The homogenate was then centrifuged at 5000 × g for 30
min to remove debris. The homogenate and supernatant
were frozen at –20 °C in aliquots until used for biochemical
assays. The protein content of the tissue was determined
using the Lowry method (Lowry et al., 1951).
2.3.1. Determination of MDA
Malondialdehyde (MDA) levels, an indicator of free
radical generation, which increases at the end of the lipid
peroxidation, were estimated by the double heating method
of Drapper and Hadley (Drapper and Hadley, 1990).
The principle of the method is the spectrophotometric
measurement of the color generated by the reaction of
thiobarbituric acid with MDA. The results were given as
nanomoles per gram wet tissue.
2.3.2. Determination of SOD activity
Total (Cu–Zn and Mn) superoxide dismutase (SOD)
activity was determined according to the method of Sun
et al. (Sun et al., 1988). The method is based, briefly, on
the inhibition of nitroblue tetrazolium (NBT) reduction
by the xanthine/xanthine oxidase system as a superoxide
generator. One unit of SOD was defined as the enzyme
amount causing 50% inhibition in the NBT reduction rate.
Activity was expressed as units per gram protein.
2.3.3. Determination of CAT activity
Catalase (CAT) activity was measured according to the
method of Aebi (Aebi, 1984). The principle of the assay
is based on the determination of the rate constant k (unit
of measure: s–1, k) of hydrogen peroxide decomposition.
By measuring the absorbance change per minute, the rate
constant of the enzyme was determined. Activities were
expressed as k (rate constant) per gram protein.
2.4. Statistical evaluation
Statistical analysis was performed with SPSS 9.0 for
biochemical parameters. One-sample Kolmogorov–
Smirnov and ANOVA tests were used for group
comparisons. P values of less than 0.05 were considered
as significant.
SPSS 9.0 for Windows was used for statistical
analysis of histopathological findings. The extent of
histopathological changes of all experimental groups for
liver tissues was semiquantitatively graded as follows: (-)
indicates no changes, and (+), (++), and (+++) indicate
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mild, moderate, and severe changes, respectively. These
values were considered to be nonparametric; therefore,
data were statistically analyzed by the Mann–Whitney U
test and P < 0.05 was considered significant.
3. Results
3.1. Histopathological findings
Liver tissue samples of the control group were normal.
Hepatocytes, portal triads, and sinusoids were normally
observed, as shown in Figure 1. There were significant
structural changes in the liver tissues of the midazolam
group as compared with the controls, as shown in Table
1. Histopathological examination of liver tissues from
the rats treated with midazolam revealed that there were
some structural changes such as granular degeneration
and pyknotic nuclei in hepatocytes, necrotic cells, vascular
congestion, hemorrhage, bile duct proliferation, and
mononuclear cell infiltration, shown in Table 1 and Figure
1. There were also some significant changes in liver tissues

Control

Midazolam

of the etomidate group when compared with the controls,
as shown in Table 1 (P < 0.05). Histopathological changes
such as granular degeneration in hepatocytes, vascular
congestion, pyknotic nuclei, bile duct proliferation, and
mononuclear cell infiltrations in perivascular and portal
areas were observed in the etomidate group, as shown
in Figure 1. Structural changes and semiquantitative
evaluation parameters are given in Table 1.
3.2. Biochemical findings
There was a slight increase in mean MDA levels in the
midazolam group when compared with the controls, but
this was not statistically significant (Figure 2). However,
there was a significant increase in hepatic SOD and CAT
levels in the midazolam group, as shown in Table 2 and
Figure 2. There was a statistically significant difference
between the etomidate group and controls in terms of
MDA, SOD, and CAT levels, as shown in Table 2 (P <
0.05). Mean values of SOD, MDA, and catalase are given
in Table 2.

Etomidate

A

B

Figure 1. Control group: Hepatocytes (black arrow), sinusoids (white arrow), central vein (asterisks), and portal areas
(asterisks) are normal in appearance (H&E) (A: 120×; B: 240×). Midazolam group: A) Bile duct proliferation (black
arrow), hepatocyte necrosis (asterisks), and hepatocyte with pyknotic nucleus (white arrow) are present. B) There is
granular degeneration of hepatocytes (black arrow), mononuclear cell infiltration in portal area (white asterisks), and
hepatocyte with pyknotic nucleus (white arrow) (H&E; A: 240×, B: 240×). Etomidate group: A) Hepatocytes with
pyknotic nuclei (black arrows) are present. B) Granular degeneration of hepatocytes (black arrows) and mononuclear
cell infiltration in portal area (asterisks) are evident. (H&E; A: 240×, B: 480×).
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Table 1. Grading of histopathological changes in liver tissues of the groups.
Experimental groups

Group I (control)
n=9

Group II (midazolam)
n=9

Group III (etomidate)
n=7

Parameters / scorea

-

+

++

+++ O

-

+

++

+++ O

-

+

++

+++ O

Hepatocyte degeneration

6

3

0

0

-

0

3

6

0

++

0

0

2

5

+++

P = 0.0001

Vascular congestion

8

1

0

0

-

2

7

0

0

+

0

2

5

0

++

P = 0.0001

Perivascular mononuclear cell infiltration

9

0

0

0

-

1

7

1

0

+

0

2

4

1

++

P < 0.0001

Hepatocyte necrosis

9

0

0

0

-

2

7

0

0

+

5

2

0

0

-

P < 0.0001

Hepatocyte with pyknotic nucleus

9

0

0

0

-

2

7

0

0

+

1

6

0

0

+

P < 0.0020

Mononuclear cell infiltration in parenchyma

9

0

0

0

-

1

7

1

0

+

6

1

0

0

-

P < 0.0001

Mononuclear cell infiltration in portal areas

9

0

0

0

-

1

7

1

0

+

0

1

6

0

++

P < 0.0001

Bile duct proliferation

9

0

0

0

-

2

7

0

0

+

6

1

0

0

-

P < 0.0001

P-values

n = Number of cases. aScore (-): no meaningful histopathological changes. Score (+): mild degree. Score (++): moderate degree. Score (+++): severe
degree.

Figure 2. Biochemicals parameter values of experimental groups in liver tissues.
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Table 2. Changes in the parameters of SOD, CAT, and MDA.
Experimental groups

SOD
(U/g protein)

CAT
(k/g protein)

MDA
(nmol/g wet tissue)

Control (n = 9)

86.01 ± 4.61

1.84 ± 0.11

10.84 ± 1.05

Midazolam (n = 9)

98.30 ± 6.62

2.08 ± 0.12

11.49 ± 0.94

Etomidate (n = 7)

132.69 ± 4.55

2.50 ± 0.11

16.86 ± 1.26

I–II

0.0001

0.002

n.s.

I–III

0.0001

0.0001

0.0001

P values

Values are expressed as mean ± SD.
n.s.: not significant

4. Discussion
Experimental studies have focused on the effects of
anesthetic agents on various organs and systems and the
liver has been the most emphasized organ in this regard
because the localization of liver is suitable for metabolite
storage, substance transformation, and/or other
detoxification processes. Harmful effects of some drugs
are prevented via oxidation, methylation, or conjugation
mechanisms in the liver (Işık, 2004, Koçkar et al., 2010).
Numerous studies have indicated that some inhalation
or intravenous anesthetic agents may cause decrease in
blood flow and hepatotoxicity (Hanquet, 1972; Fassoulaki
et al., 1986; Atiba et al., 1988; Fee et al., 1997). It has also
been reported that lower doses of midazolam have no
effect on enzymatic induction, whereas administration of
midazolam at repeated or high doses can lead to elevation
in enzymatic activity levels, hepatic functional disorders,
and tissue damage in the liver (Amrein and Hetzel, 1990;
Nilsson, 1991). During the cellular metabolism process,
some cytotoxic free radicals occur. Such compounds
include superoxide anions, hydroxyl radical, hydrogen
peroxide, and some other radicals. Interaction between the
reactive oxygen species (ROS) and cellular macromolecules
can result in oxidative damage and cellular dysfunction.
ROS especially affect the polyunsaturated fatty acid
unit of membrane phospholipids in cells and lead to
the formation of hydroperoxides via the peroxidation
pathway. Hydroperoxides in turn lead to an increase in
ROS amount. This cascade may cause severe cellular
damage and cell death (Özcan et al., 1992; Bachowski et
al., 1997; Ceylan et al., 2011). In numerous studies, it has
been reported that some intravenous anesthetic agents
cause an increase in ROS production and tissue damage
as an indicator of deleterious effects (Fassoulaki et al.,
1986; Murphy et al., 1993; Okutomi et al., 1995; Abidova,
2002). Hoen et al. (2001) reported that intraperitoneal

administration of midazolam to rats at a dose of 50 mg/kg
resulted in 4-fold increase in cytochrome P-450 (CYP-3A)
isoenzyme expression. MDA is a substance produced as a
result of the interaction between ROS and cell membranes
and it is an important indicator for lipid peroxidation
(Nazıroğlu et al., 2004). MDA can lead to damage in the
plasma membrane, deterioration of cellular homeostasis,
and loss in ion transport systems and intercellular gap
junction communication (Özcan et al., 1992). The
antioxidant enzyme system is the most important defense
mechanism against membrane damage induced by lipid
peroxidation in mammalian cells. CAT is another enzyme
that catalyzes the dissociation of hydrogen peroxide
and other lipid peroxides, thereby protecting the cell
membranes and hemoglobins against oxidation (Bleecker
et al., 1994; Nazıroğlu, 2012). CAT is present in virtually
all cells in the body and it is especially effective in the
case of high hydrogen peroxide concentrations (Bushnell
et al., 1994; Nazıroğlu, 2012). CAT enzyme activity may
show huge diversity in various organs. The liver and
kidneys are the organs with the highest CAT activity.
SOD enzyme protects oxygen-catabolizing cells against
the harmful effects of superoxide free radical and inhibits
lipid peroxidation (Niwa et al., 1990; Fatmi et al., 2013).
SOD activity is high in tissues that use much oxygen and
it increases in parallel to the partial oxygen pressure of
the tissue (Lunec and Blake, 1990). SOD also plays a role
in intracellular termination of the phagocytized bacteria
(Kobayaski et al., 1977).
Our study is the first that evaluates the changes in
hepatic MDA, SOD, and CAT levels following midazolam
administration. There was a statistically significant
difference between the midazolam group and the controls
in SOD and CAT enzyme activity levels, suggesting the
increase in the formation of superoxide radicals and
hydrogen peroxide production. However, there was no
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difference between the controls and the study groups in
MDA levels. This may indicate that the antioxidant system
is effective enough to prevent a possible lipid peroxidation
reaction. There were some structural changes in liver
tissue sections of the midazolam group when compared
with the controls. These structural changes include
moderate granular degeneration in hepatocytes and slight
mononuclear cell infiltrations in the parenchyma.
Drug biotransformation is an important function
of the liver. The biotransformation function is related
to anesthesia in two ways: the sensitivity of microsomal
enzymes to induction and the acceleration of drug
biotransformation. It has been indicated that inhalation
anesthetics and barbiturate-type drugs lead to enzymatic
induction (Gillman et al., 1991). In a previous study, it
was reported that etomidate led to a reversible inhibition
in microsomal enzyme activity in rabbit liver. This
inhibition may suggest the possibility that etomidate led
to a deleterious effect in hepatic tissue via binding to the
cytochrome P450 system with high affinity (Horai et al.,
1985). In another study, it was indicated that etomidate
causes inhibition in drug elimination in the human liver;
however, this process could be carried out as hepatic

clearance rate of etomidate is low (Atiba et al., 1972). Our
study is the first that aims to investigate the changes in
hepatic MDA, SOD, and CAT enzymatic activity levels
due to etomidate administration. There was a significant
increase in hepatic SOD and CAT activity levels in rats
given etomidate when compared with the controls.
However, there was also a prominent increment in MDA
levels in this group. Increase in antioxidant enzyme
activity along with the MDA levels may suggest that the
antioxidant defense system can interfere with free radical
accumulation but cannot stop lipid peroxidation. We
have observed that repeated administration of etomidate
at high doses has led to some histopathological and
biochemical changes, whereas midazolam administration
did not cause lipid peroxidation but did give rise to some
histopathological changes. As a result, we conclude that
one must be cautious about the dose and duration in the
administration of these anesthetic agents during surgical
interventions.
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